ANSTO confirms another shutdown at Mo-99 facility

The Australian Nuclear Science and Technology Organization (ANSTO) confirmed it has shut down its Lucas Heights nuclear medicine facility following a “mechanical fault,” The Guardian reported. The shutdown puts an added strain on Australia’s already short supply of molybdenum-99 (Mo-99).

According to ANSTO, there are “no safety implications” from this shutdown, and said they had secured a limited supply of Mo-99, but admitted doctors will have to adapt.

“This will be a crisis by next week,” said Peter Tually, director of Kalgoorlie Medical Imaging in Western Australia, to the Guardian. “I’m going to be presented with six or seven referrals and I’m going to have to make a decision about who I can see and who I can’t.”

The Lucas Heights facility is one of 11 reactors in the world, but has experienced many problems. Most recently, ANSTO halted all production after three workers were exposed to radiation from a contaminated container full of Mo-99.

Read the full story below.  

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.